¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cyto"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cytolysis
    ¼¼Æ÷¿ëÇØ
  • cytolysosome
    ¼¼Æ÷¿ëÇØ¼Òü
  • cytolytic
    ¼¼Æ÷¿ëÇØ-
  • cytolytic antibody
    ¼¼Æ÷¿ëÇØÇ×ü
  • cytolytic ferment
    ¼¼Æ÷¿ëÇØ¹ßÈ¿¼Ò
  • cytomegalic
    ¼¼Æ÷°Å´ë-
  • cytomegalic inclusion
    ¼¼Æ÷°Å´ëÆ÷ÇÔ¹°
  • cytomegalic inclusion body
    ¼¼Æ÷°Å´ëÆ÷ÇÔü, ¼¼Æ÷°Å´ëºÀÀÔü
  • cytomegalic inclusion disease
    °Å´ë¼¼Æ÷Æ÷ÇÔº´, °Å´ë¼¼Æ÷ºÀÀÔüº´
  • cytomegalovirus
    °Å´ë¼¼Æ÷¹ÙÀÌ·¯½º
  • cytomegalovirus retinitis
    °Å´ë¼¼Æ÷¹ÙÀÌ·¯½º¸Á¸·¿°, »çÀÌÅä¸Þ°¥·Î¹ÙÀÌ·¯½º¸Á¸·¿°
  • cytomere
    1. ¿øÇüÁú 2. Æ÷ÀÚÃæ»ý 3. ½Äü 4. Á¤ÀÚºÐÀý
  • cytometaplasia
    ¼¼Æ÷È­»ý
  • cytometer
    ¼¼Æ÷°è»ê±â, ¼¼Æ÷ÃøÁ¤±â
  • cytometry
    ¼¼Æ÷°è»ê(¹ý), ¼¼Æ÷ÃøÁ¤(¹ý)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cytolytic antibody
    ¼¼Æ÷¿ëÇØÇ×ü
  • cytolytic ferment
    ¼¼Æ÷¿ëÇØ¹ßÈ¿¼Ò
  • cytolytic toxin
    ¼¼Æ÷¿ëÇØµ¶¼Ò
  • cytomegalic inclusion
    ¼¼Æ÷°Å´ëÆ÷ÇÔ¹°
  • cytomegalic inclusion body
    ¼¼Æ÷°Å´ëºÀÀÔü, ¼¼Æ÷°Å´ëÆ÷ÇÔü
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÆ÷ÇÔº´
  • cytomegalovirus
    °Å´ë¼¼Æ÷¹ÙÀÌ·¯½º
  • cytomegalovirus retinitis
    ½ÃÅä¸Þ°¥·Î¹ÙÀÌ·¯½º¸Á¸·¿°, °Å´ë¼¼Æ÷¹ÙÀÌ·¯½º¸Á¸·¿°
  • cytomere
    ¿øÇüÁú, Æ÷ÀÚÃæ»ý½Äü, Á¤ÀÚºÐÀý
  • cytometaplasia
    ¼¼Æ÷È­»ý
  • cytometer
    ¼¼Æ÷°è»ê±â, ¼¼Æ÷ÃøÁ¤±â
  • cytometry
    ¼¼Æ÷°è»ê, ¼¼Æ÷ÃøÁ¤
  • cytomorphosis
    ¼¼Æ÷ÇüŹ߻ý, ¼¼Æ÷º¯ÅÂ
  • cyton
    (¢¡perikaryon) ¼¼Æ÷ü
  • cytopathic
    ¼¼Æ÷º¯¼º-
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cytoglobin
    ½ÃÅä±Û·Îºó.
  • cytoglycopenia
    Ç÷±¸Æ÷µµ´ç°¨¼Ò(¡­øãÔ¬ÓØ Êõá´).
  • cytohistology
    ¼¼Æ÷Á¶Á÷ÇÐ(¡­ðÚòÄùÊ).
  • cytokeratin
    »çÀÌÅäÄɶóƾ<<Á¶Á÷Çü ÁöÇ¥·Î½áÀÇ>>
  • cytokeratin antigen
    ¼¼Æ÷ °¢Áú Ç׿ø(á¬øà ÊÇòõ ù÷ê«)
  • cytokeratin antigen
    ¼¼Æ÷ °¢ÁúÇ׿ø
  • cytokine
    »çÀÌÅäÄ«ÀÎ, ¼¼Æ÷È£¸£¸ó.
  • cytokine
    »çÀÌÅäÄ«ÀÎ
  • cytokine
    ½ÃÅäÄ«ÀÎ
  • cytokines
    »çÀÌÅäÄ«ÀÎ
  • cytokinesis
    ¼¼Æ÷(Áú)ºÐ¿­(¡­òõÝÂæñ).
  • cytokinesis
    ¼¼Æ÷ÁúºÐ¿­
  • cytokinetics
    ¼¼Æ÷µ¿·ÂÇÐ(¡­ÔÑæ³ùÊ).
  • cytologic examination
    ¼¼Æ÷ÇÐÀû °Ë»ç
  • cytological fixation
    ¼¼Æ÷ÇÐÀû °íÁ¤(¡­ùÊîÜͳïÒ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cytomembrane
    ¼¼Æ÷¸·(á¬øàØ¯)
  • cytophilic antibody
    ¼¼Æ÷ģȭÇ×ü(á¬øàöÑûúù÷ô÷)
  • cytophotometry
    ¼¼Æ÷Ãø±¤¹ý(á¬øàö´ÎÃÛö)
  • cytoplasm
    ¼¼Æ÷Áú(á¬øàòõ)
  • cytoplasmic gene
    ¼¼Æ÷Áú À¯ÀüÀÚ(á¬øàòõë¶îîí­)
  • cytoplasmic inheritance
    ¼¼Æ÷Áú À¯Àü(á¬øàòõë¶îî)
  • cytoplasmic membrane
    "¼¼Æ÷Áú ¸·(á¬øàòõد), (ÔÒ) cell membrane"
  • cytoplasmon
    »çÀÌÅäÇö󽺸ó
  • cytoplast
    ¼¼Æ÷Áúü(á¬øàòõô÷)
  • cytoribosome
    ¼¼Æ÷¶óÀ̺¸¼Ø
  • cytosegresome
    ¼¼Æ÷¿ëÇØÃ¼(á¬øàéÁú°ô÷)
  • cytoside
    »çÀÌÅä½Ãµå
  • cytosine
    »çÀÌÅä½Å
  • cytosine arabinoside
    »çÀÌÅä½Å ¾Æ¶óºñ³ë»çÀ̵å
  • cytoskeleton
    ¼¼Æ÷°ñ°Ý(á¬øàÍéÌ«)
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • JrId: 3332
    JournalTitle: Cytobiologie.
    MedAbbr: Cytobiologie
    ISSN: 0070-2463
    ESSN:
    IsoAbbr:
    NlmId: 235440
  • JrId: 20421
    JournalTitle: Cytokine & growth factor reviews.
    MedAbbr: Cytokine Growth Factor Rev
    ISSN: 1359-6101
    ESSN:
    IsoAbbr: Cytokine Growth Factor Rev.
    NlmId: 9612306
  • JrId: 20690
    JournalTitle: Cytokines, cellular & molecular therapy.
    MedAbbr: Cytokines Cell Mol Ther
    ISSN: 1368-4736
    ESSN:
    IsoAbbr: Cytokines Cell. Mol. Ther.
    NlmId: 9713367
  • JrId: 20747
    JournalTitle: Cytokines and molecular therapy.
    MedAbbr: Cytokines Mol Ther
    ISSN: 1355-6568
    ESSN:
    IsoAbbr:
    NlmId: 9509183
  • JrId: 27065
    JournalTitle: Cytotherapy.
    MedAbbr: Cytotherapy
    ISSN: 1465-3249
    ESSN:
    IsoAbbr:
    NlmId: 100895309
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cytoproximal
    ¼¼Æ÷ ±ÙÀ§ÀÇ
    ±â¿ø ¼¼Æ÷¿¡ ±ÙÁ¢ÇÑ Ãà»èÀÇ ºÎºÐÀ» ÀǹÌ.
  • cytorrhyctes
    ¼¼Æ÷ ºÀÀÔü
    ¿©·¯ °¡Áö Áúȯ¿¡¼­ º¼ ¼ö ÀÖ´Ù. À̰ÍÀº Ư¼öÇÑ ¿ø»ýµ¿¹°ÀÇ º´¿øÃ¼ÀÎ °æ¿ì¿Í, ÁúȯÀÇ ±â»ýÃæ¿¡ ´ëÇÑ ¼¼Æ÷ÀÛ¿ëÀÇ Ç¥ÇöÀÎ °æ¿ì, Áúȯ¿¡ ÀÇÇÏ¿© »ý±ä º¯¼ºÀÎ °æ¿ì µîÀÌ ÀÖ´Ù.
  • cytosine
    ½ÃÅä½Å
    ÇÙ»êÀ» ±¸¼ºÇÏ´Â ¿°±âÀÇ Çϳª. 2-¿Á½Ã-6-¾Æ¹Ì³ëÇǸ®¹Ìµò¸¦ ¸»ÇÑ´Ù. RNA, DNA ¸ðµÎ¿¡ Æ÷ÇԵȴÙ. 1894³â¿¡ A. ÄÚ¼¿°ú ³ëÀ̸¸ÀÌ ¼Û¾ÆÁö Èä¼±ÀÇ °¡¼öºÐÇØ¹°¿¡¼­ ºÐ¸®ÇÏ¿´´Ù. 1ºÐÀÚÀÇ °áÁ¤¼ö¸¦ °¡Áø ÆÇ»ó °áÁ¤À¸·Î ¾ò¾îÁö¸ç È£º¯ À̼ºÃ¼
  • cytosine arabinoside
    »çÀÌÅä½Å ¾Æ¶óºñ³ë»çÀ̵å
  • cytosis
    ¹éÇ÷±¸ »óÅÂ
  • cytoskeleton
    ¼¼Æ÷ °ñ°Ý
    ¼¼Æ÷ÀÇ ¼¼Æ÷Áú ³»¿¡ ÀÖ´Â ÇöÀúÇÑ ³»ºÎÀÇ °­È­ ¹°Áú. Àå¿ø ¼¶À¯. ¼¶À¯¸Á ±¸Á¶ ȤÀº, ´Ù¸¥ ¹Ì¼¼»ç·Î ÀÌ·ç¾îÁø´Ù.
  • cytosolic
    »çÀÌÅä¼ÖÀÇ, ¼¼Æ÷¼ÖÀÇ
    cytosol¿¡ ÇÔÀ¯µÈ. cytosol¿¡ °üÇØ.
  • cytospongium
    ¼¼Æ÷ ÇØ¸éÁú
    µ¿ÀǾî=s
  • cytostasis
    ¼¼Æ÷¼º »öÀü, ¹éÇ÷±¸ ¸ð¼¼°ü Àü»ö
    ¿°ÁõÀÇ Ãʱ⠴ܰ迡 ÀÖ¾î ¹éÇ÷±¸¿¡ ÀÇÇÏ¿© ¸ð¼¼Ç÷°üÀÌ Æä¼âµÇ´Â °Í.
  • cytostatic agent
    ¼¼Æ÷ Áõ½Ä ¾ïÁ¦ ¾à¹°
  • cytosteatonecrosis
    ¼¼Æ÷ Áö¹æ ±«»ç
  • cytotactic
    ¼¼Æ÷ ÁÖ¼ºÀÇ
  • cytotherapy
    ¼¼Æ÷ ¿ä¹ý
    1. µ¿¹°¼¼Æ÷ÀÇ Åõ¿©¿¡ ÀÇÇÑ Ä¡·á. 2. ¼¼Æ÷ ¿ëÇØ¼º ¶Ç´Â ¼¼Æ÷ »óÇØ¼º Ç÷ûÀÇ Ä¡·áÀû »ç¿ë.
  • cytotoxic
    ¼¼Æ÷ µ¶¼º
    ¼¼Æ÷ µ¶¼Ò¿¡ ÀÇÇÑ. ¼¼Æ÷ µ¶ ÀÛ¿ëÀ» Áö´Ñ.
  • cytotoxic antibody
    ¼¼Æ÷ µ¶ Ç×ü, ¼¼Æ÷ µ¶¼º Ç×ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
cytochrome c2 reductase <enzyme> An enzyme catalyzing the reduction of 2 ferricytochrome c2 to 2 ferrocytochrome c2 at the expense of NADPH.
Synonym: cytochrome c2 reductase.
(05 Mar 2000)
cytochrome c3 hydrogenase A hydrogenase enzyme catalyzing reduction of 2ferricytochrome c3 by H2 to 2ferrocytochrome c3 and 2H+.
(05 Mar 2000)
cytochrome C553 peroxidase <enzyme> A haem group of cytochrome-c peroxidase (EC 1.11.1.5); catalytically active in both the oxidised and half-reduced states; from nitrosomonas europaea; partial amino acid sequence given in first source
Registry number: EC 1.11.1.-
(26 Jun 1999)
cytochrome cd cytochrome oxidase (Pseudomonas)
cytochrome d <chemical> Cytochromes (electron-transporting proteins) with a tetrapyrrolic chelate of iron as a prosthetic group in which the degree of conjugation of double bonds is less than in porphyrin.
Chemical name: Cytochrome d
(12 Dec 1998)
cytochrome oxidase <enzyme> Terminal enzyme of the electron transport chain that accepts electrons from (i.e. Oxidizes) cytochrome C and transfers electrons to molecular oxygen.
(18 Nov 1997)
cytochrome p-450 <biochemistry> Enzymes of the electron transport chain that are pigmented by virtue of their haem prosthetic groups.
They are highly conserved isozymes which are key components of the mixed-function oxidase system responsible for the biotransformation of many foreign compounds to mutagens and carcinogens.
Most mammals have several distantly related phenobarbital-inducible gene subfamilies.
(21 Jun 2000)
cytochrome p-450 cyp11b2 <enzyme> A multifunctional enzyme that catalyses the conversion of corticosterone to 18-hydroxycorticosterone and the subsequent conversion of 18-hydroxycorticosterone to aldosterone.
Registry number: EC 1.14.99.-
(12 Dec 1998)
cytochrome p-450 cyp1a1 <enzyme> A cytochrome p-450 enzyme capable of activating procarcinogenic polycyclic hydrocarbons and halogenated aromatic hydrocarbons into mutagenic compounds. Ethoxyresorufin acts as a substrate for cyp1a1 and measurement of ethoxyresorufin o-deethylase provides a more direct method of detection for this enzyme.
Registry number: EC 1.-
(12 Dec 1998)
cytochrome p-450 cyp1a2 <enzyme> A polycyclic aromatic hydrocarbon-inducible cytochrome which is of significant clinical interest due to the large number of drug interactions associated with induction and inhibition of theophylline. Caffeine is considered to be a model substrate for this enzyme. It also metabolises theophylline and antipyrene. Environmental factors including cigarette smoking, charbroiled meat, cruciferous vegetables, and a number of drugs including phenytoin, phenobarbital, and omeprazole produce increases in cyp1a2 activity.
Registry number: EC 1.-
(12 Dec 1998)
cytochrome p-450 cyp2b1 <enzyme> A major cytochrome p-450 enzyme which is inducible by phenobarbital in both the liver and small intestine. It is active in the metabolism of compounds like pentoxyresorufin, testosterone, and androstenedione. Cyp2b1 also mediates the activation of cyclophosphamide and ifosfamide to mutagens.
Registry number: EC 1.-
(12 Dec 1998)
cytochrome p-450 cyp2d6 <enzyme> A polymorphic enzyme that catalyses the hydroxylation of debrisoquine. It also metabolises several antidepressants and neuroleptics. This enzyme is deficient in up to 10 percent of the population.
Registry number: EC 1.14.99.-
(12 Dec 1998)
cytochrome p-450 cyp2e1 <enzyme> A polymorphic enzyme that activates carcinogenic n-nitrosamines, benzene, urethane, and other low molecular weight compounds. It is inducible by ethanol and metabilises alcohol. Experimentally, it is used to study the effects of ethanol usage and withdrawal via enzyme markers such as n-nitrosodimethylamine demethylase.
Registry number: EC 1.5.99.-
(12 Dec 1998)
cytochrome P-450 oxidase <enzyme> Oxidises NADPH with formation of hydrogen peroxide
Registry number: EC 1.6.2.-
Synonym: NADPH-p450 reductase, NADPH-cytochrome p450 reductase, cytochrome p450 reductase, cpra gene product
(26 Jun 1999)
cytochrome P-450-dependent digitoxin 12beta-hydroxylase <enzyme> Isolated from digitalis lantata cell cultures
Registry number: EC 1.14.99.-
Synonym: digitoxin 12beta-hydroxylase
(26 Jun 1999)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 3
  • Cytochrome P-450 CYP27A1 - »õâ An NAPH-dependent cytochrome P450 enzyme that catalyzes the oxidation of the side chain of sterol intermediates such as the 27-hydroxylation of 5-beta-cholestane-3-alpha,7-alpha, 12-alpha-triol. Cytochrome P-450 CYP27A1 is a mitochondrial enzyme; however microsomal-derived homologs of the enzyme have been identified and are included under this heading.
    Synonyms : 5-beta-Cholestane-3-alpha, 7-alpha, 12-alpha-triol 27-Hydroxylase, C27-Steroid 26-Hydroxylase, Cholestanetriol 26-Monooxygenase, Cytochrome P-450 CYP2R1, Cytochrome P-450 Steroid 27-Hydroxylase, Cytochrome P-450 Sterol 26-Hydroxylase, Cytochrome P450 2R1
  • Cytochrome P-450 CYP2B1 - »õâ A major cytochrome P-450 enzyme which is inducible by PHENOBARBITAL in both the LIVER and SMALL INTESTINE. It is active in the metabolism of compounds like pentoxyresorufin, TESTOSTERONE, and ANDROSTENEDIONE. This enzyme, encoded by CYP2B1 gene, also mediates the activation of CYCLOPHOSPHAMIDE and IFOSFAMIDE to MUTAGENS.
    Synonyms : 7-Benzyloxyresorufin O-Dealkylase, 7-Pentylresorufin O-Depentylase, CYP 2B1, Cytochrome P450 2B1, 7 Benzyloxyresorufin O Dealkylase, 7 Pentylresorufin O Depentylase, Benzyloxyresorufin O Dealkylase, Cytochrome P 450 CYP2B1, O-Dealkylase, Pentoxyresorufin
  • Cytochrome P-450 CYP2D6 - »õâ A cytochrome P450 enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as DEBRISOQUINE; ADRENERGIC RECEPTOR ANTAGONISTS; and TRICYCLIC ANTIDEPRESSANTS. This enzyme is deficient in up to 10 percent of the Caucasian population.
    Synonyms : CYP 2D6, Cytochrome P450 2D6, Debrisoquine 4-Monooxygenase, Imipramine 2-Hydroxylase, Sparteine Monooxygenase, 2-Hydroxylase, Imipramine, 4-Hydroxylase, Debrisoquine, 4-Monooxygenase, Debrisoquine, CYP2D6, Cytochrome P-450, Cytochrome P 450 CYP2D6
  • Cytochrome P-450 CYP2E1 - »õâ An ethanol-inducible cytochrome P450 enzyme that metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Substrates include alcohol; NITROSAMINES; BENZENE; URETHANE; and other low molecular weight compounds. CYP2E1 has been used as an enzyme marker in the study of alcohol abuse.
    Synonyms : CYP 2E1, CYP IIE1, CYPIIE1, Cytochrome P-450 (ALC), Cytochrome P-450 IIE1, Cytochrome P-450-J, Cytochrome P450 2E1, N-Nitrosodimethylamine Demethylase, 4 Nitrophenol 2 Hydroxylase, Cytochrome P 450 CYP2E1, Cytochrome P 450 IIE1, Cytochrome P 450 J
  • Cytochrome P-450 CYP3A - »õâ A cytochrome P-450 monooxygenase that is involved in an NADPH-dependent electron transport pathway by oxidizing a variety of structurally unrelated compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN.
    Synonyms : Cytochrome P-450IIIA, Cytochrome P450 3A, Erythromycin N-Demethylase, Cytochrome P 450 CYP3A, Cytochrome P 450IIIA, Erythromycin N Demethylase, N-Demethylase, Erythromycin, P-450 CYP3A, Cytochrome, P-450IIIA, Cytochrome, P450 3A, Cytochrome
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
cytosol the aqueous part of the cytoplasm within which various particles and organelles are suspended
Ãâó: wordnet.princeton.edu/perl/webwn
cytoarchitecture the cellular composition of a bodily structure
Ãâó: wordnet.princeton.edu/perl/webwn
cytogeneticist a geneticist who specializes in the cellular components associated with heredity
Ãâó: wordnet.princeton.edu/perl/webwn
cytokinetic of or relating to the division of the cytoplasm of a cell following the division of the nucleus
Ãâó: wordnet.princeton.edu/perl/webwn
cytologic cytological: of or relating to the science of cytology
Ãâó: wordnet.princeton.edu/perl/webwn
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
Cyto any substance that has a toxic effect on cells
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 3
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á